There is an urgent need to improve global maternal health.


One of the ways Thermo Fisher is helping to meet this need is by innovating to advance preeclampsia diagnostics.


Last year, we launched the industry's first, FDA-cleared blood test to help determine a pregnant woman’s risk of developing preeclampsia with severe features – a condition that impacts hundreds of thousands of women each year. With this dangerous condition on the rise at alarming rates, it's important to make this condition more well-known.


In our exclusive video, Yolando Carrillo shares her story of how the test played a pivotal role in her care and that of her unborn baby.